RE: NT to sell10 May 2024 10:18
Great news for the team and patients. Congratulations to all the team.
However, for us the shareholders not as such good news. A few people making their 10% after the recent falls are now selling, good luck to them. But for long term holders, we are majorily down from the high of 20p+ we are down from the yearly high of 5p+
So we have a drug going through clinical trials that has ODD, fast track approval, EAP status, now PRDD.
We all agree the FDA seem to like it and are trying to help it gain approval.
We have the possibility of a massive PRV if we get approval before the sunset deadline.
Our IB technology is being used at many medical facilities including research facilities and is touted as world leading.
AND the company mcap is less than £4m
The world leading technology and possible drug approval doesn’t seem to fit with the Mcap in my mind. What is going to improve the sp, are we going to do more marketing, publicity etc.
How is TB and the board going to sort out the sp? It could be a very interesting AGM.
Have a good weekend everybody
Thanks